Clinical trials
Breast - Female clinical trials
Below are recruiting breast - female clinical trials, each written for real people, not researchers. We’re tracking 3,707 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06605586RecruitingPhase 1/Phase 2
Test of tasquinimod for myelofibrosis that stopped responding to JAK inhibitor therapy
This trial tests an oral drug called tasquinimod for people with myelofibrosis that no longer responds to or cannot take a JAK inhibitor. The goal is to see if tasquinimod can help shrink an enlarged spleen and improve symptoms.
AachenAges 18 years+ - NCT06606535Recruiting
Effects of hormone therapy on thinking skills in breast cancer
This study examines how certain hormone-lowering drugs (aromatase inhibitors) used after breast cancer treatment may affect memory, thinking, and concentration. It may help patients understand potential side effects on cognitive function.
Genova, GEAges 18 years+ - NCT06606730RecruitingPhase 3
Personalized pembrolizumab after strong chemo response for early triple-negative breast cancer
This trial is for people with early triple-negative breast cancer who had a strong response to chemotherapy combined with pembrolizumab before surgery. It aims to find the best way to continue using pembrolizumab after surgery to reduce the risk of cancer coming back.
BrusselsAges 18 years+ - NCT06608446Recruiting
Rehab from home after breast cancer surgery
This study tests a remote physical therapy program to help manage complications after breast cancer surgery. It may help you recover movement and reduce discomfort without needing to travel to a clinic.
Roma, RomaAges 18 years+ - NCT06609668Recruiting
Thrombomodulin blood test to rule out giant cell arteritis in PMR
This study tests whether a blood test for a protein called thrombomodulin can help rule out giant cell arteritis (a blood vessel inflammation) in people with polymyalgia rheumatica. It involves a blood draw and a one-time imaging scan to look at your blood vessels.
DijonAges 50 years+ - NCT06610539Recruiting
Magnetic tracer for sentinel node biopsy in breast cancer
This study tests a magnetic tracer call Magtrace to help find and remove the first lymph node (sentinel node) during breast cancer surgery. The goal is to see if it works well for people having breast-conserving surgery.
Chapel Hill, North CarolinaAges 18 years+ - NCT06610565Recruiting
Fasting-mimicking diet for breast cancer side effects
This study tests if a special diet that mimics fasting can help reduce side effects from hormone therapy (aromatase inhibitors) in women with breast cancer. The diet is a low-calorie meal plan designed to lower cholesterol and improve well-being.
Milan, ItalyAges 18 years+ - NCT06611007RecruitingPhase 1/Phase 2
Lipiodol injections for painful finger arthritis not helped by usual treatments
This trial tests if injecting a special dye (Lipiodol) into the blood vessels of the fingers can safely reduce pain and symptoms in people with hand osteoarthritis that hasn't responded to standard pain relievers.
ÉchirollesAges 40 years+ - NCT06612827Recruiting
Using tumor organoids to guide treatment for rare cancer
This study is creating lab-grown mini-tumors (organoids) from your cancer to help doctors choose the best treatment for you. If you have a rare undifferentiated primary carcinoma, your tumor sample could be used to test different drugs before you receive them.
CaenAges 18 years+ - NCT06614595Recruiting
Transfusion and quality of life in lower-risk MDS
This study looks at how well transfusions work and how they affect quality of life in people with lower-risk MDS who need regular blood transfusions. The goal is to find what predicts a good transfusion response and to improve care.
Oviedo, Principality of AsturiasAges 18 years+ - NCT06615466Recruiting
Short radiation course for early stage breast cancer
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
Beijing, Beijing MunicipalityAges 45–74 - NCT06618872Recruiting
Comparing tau and amyloid PET scans for memory problems
This study compares two types of brain PET scans (tau and amyloid) to see which one better helps diagnose memory problems. You may be eligible if you have mild cognitive impairment or mild dementia and your doctor has already ordered an amyloid PET scan.
Geneva, Canton of GenevaAges 50–85 - NCT06621459Recruiting
Study of abemaciclib safety for breast cancer patients
This study looks at real-world safety and side effect management of abemaciclib combined with hormone therapy for patients with RH+, HER2- breast cancer. It aims to understand how well patients tolerate treatment outside of clinical trials.
BrestAges Any age - NCT06622382Recruiting
Weight loss study using a new procedure called BEAM
This study tests a procedure called BEAM to help people with obesity lose weight. It is for people who have tried other weight loss methods like diet, exercise, and medication but haven't succeeded.
ShatinAges 18–70 - NCT06622434RecruitingPhase 1/Phase 2
Vaccine for glioblastoma after standard treatment
This trial tests an experimental vaccine for glioblastoma, given after the usual radiation and chemotherapy (temozolomide). The goal is to see if the vaccine helps the immune system fight remaining cancer cells.
Paris, IdfAges 18–75 - NCT06622954Recruiting
Can a special diet protect the heart during breast cancer treatment?
This trial tests if a special diet can help prevent heart problems caused by chemotherapy in women with triple negative breast cancer. If you're starting a specific type of chemo, you may be able to join.
Rotterdam, South HollandAges 18–75 - NCT06624046Recruiting
Sleep and glucose study for type 1 diabetes
This study looks at how sleep affects blood sugar and heart health in people with type 1 diabetes. If you have irregular sleep and want to improve it, researchers will test a wearable device and sleep coaching.
Chicago, IllinoisAges 18–50 - NCT06624865Recruiting
Gut bacteria and small-intestine neuroendocrine tumor study
This study looks at how bacteria in your gut may affect the growth of small-intestine neuroendocrine tumors. If you are having surgery to remove one of these tumors, the research team will collect samples and data to better understand the link between your gut bacteria and the tumor.
Lyon, FranceAges 18 years+ - NCT06625073RecruitingPhase 4
SGLT2i for heart transplant recipients
This trial is testing a medication called SGLT2i (a type of diabetes drug that also helps the heart and kidneys) in people who have received a heart transplant. It aims to see if this drug can improve health after transplant.
Palo Alto, CaliforniaAges 18 years+ - NCT06625775RecruitingPhase 1
Study of BBO-10203 for advanced solid tumors
This trial tests a new drug called BBO-10203, alone or combined with other cancer treatments, for people with certain advanced breast, colorectal, or lung cancers. It aims to see if the drug is safe and effective.
Duarte, CaliforniaAges 18 years+ - NCT06626516RecruitingPhase 1/Phase 2
Tebentafusp and LDT for metastatic uveal melanoma
This trial tests a combination of two drugs (tebentafusp and a liver-directed treatment called LDT) for people with uveal melanoma that has spread to the liver. The goal is to see if this combination helps shrink tumors and improve outcomes.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06627504Recruiting
Sleep study for teens with type 1 diabetes
This study tests whether getting more sleep helps improve metabolic health in teens with type 1 diabetes who are not getting enough sleep. If you are between 14 and 19, use an insulin pump, and typically sleep 7 hours or less on school nights, you may be eligible.
Aurora, ColoradoAges 14–19 - NCT06627738RecruitingPhase 2
Extra radiation boost for advanced lung cancer after standard treatment
This trial tests whether adding a precise, high-dose radiation boost (CyberKnife) after standard chemoradiation can improve outcomes for people with stage III non-small cell lung cancer that cannot be surgically removed. It is for those who have already completed two cycles of induction chemo and at least 40 Gy of radiation with chemo.
NiceAges 18 years+ - NCT06628154RecruitingEarly Phase 1
Losartan and emotional learning in anhedonia
This study tests whether a blood pressure medication called losartan can help people with anhedonia (reduced ability to feel pleasure) learn better from emotional experiences. It involves taking losartan and completing computer tasks over several visits.
Oxford, OxfordshireAges 18–50
Hear when a new Breast - Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast - female?
- Yes. Clin2 currently lists 3,707 recruiting breast - female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast - female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast - female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.